Your browser doesn't support javascript.
loading
A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
Han, Kathy; Fyles, Anthony; Shek, Tina; Croke, Jennifer; Dhani, Neesha; D'Souza, David; Lee, Ting-Yim; Chaudary, Naz; Bruce, Jeffrey; Pintilie, Melania; Cairns, Rob; Vines, Douglass; Pakbaz, Sara; Jaffray, David; Metser, Ur; Rouzbahman, Marjan; Milosevic, Michael; Koritzinsky, Marianne.
Affiliation
  • Han K; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Fyles A; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Shek T; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Croke J; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Dhani N; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • D'Souza D; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Lee TY; Quantitative Imaging for Personalized Cancer Medicine, Techna Institute, University Health Network, Toronto, Ontario, Canada.
  • Chaudary N; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Bruce J; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Pintilie M; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Cairns R; London Regional Cancer Program, London Health Sciences Centre, Department of Oncology, Western University, London, Ontario, Canada.
  • Vines D; London Regional Cancer Program, London Health Sciences Centre, Department of Oncology, Western University, London, Ontario, Canada.
  • Pakbaz S; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Jaffray D; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Metser U; Department of Biostatistics, University Health Network, Toronto, Ontario, Canada.
  • Rouzbahman M; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Milosevic M; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Koritzinsky M; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Clin Cancer Res ; 28(24): 5263-5271, 2022 12 15.
Article in En | MEDLINE | ID: mdl-36037303
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / COVID-19 / Metformin / Nitroimidazoles Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / COVID-19 / Metformin / Nitroimidazoles Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States